Vidal M - Search Results

1

Design and synthesis of C-terminal modified cyclic peptides as VEGFR1 antagonists.

Wang L, Gagey-Eilstein N, Broussy S, Reille-Seroussi M, Huguenot F, Vidal M, Liu WQ. Wang L, et al. Among authors: vidal m. Molecules. 2014 Sep 26;19(10):15391-407. doi: 10.3390/molecules191015391. Molecules. 2014. PMID: 25264829 Free PMC article.

2

Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domain.

Liu WQ, Vidal M, Gresh N, Roques BP, Garbay C. Liu WQ, et al. Among authors: vidal m. J Med Chem. 1999 Sep 9;42(18):3737-41. doi: 10.1021/jm9911074. J Med Chem. 1999. PMID: 10479306

3

Inhibition of the ras-dependent mitogenic pathway by phosphopeptide prodrugs with antiproliferative properties.

Liu WQ, Vidal M, Mathé C, Périgaud C, Garbay C. Liu WQ, et al. Among authors: vidal m. Bioorg Med Chem Lett. 2000 Apr 3;10(7):669-72. doi: 10.1016/s0960-894x(00)00077-9. Bioorg Med Chem Lett. 2000. PMID: 10762050

4

Inhibitors of Ras signal transduction as antitumor agents.

Garbay C, Liu WQ, Vidal M, Roques BP. Garbay C, et al. Among authors: vidal m. Biochem Pharmacol. 2000 Oct 15;60(8):1165-9. doi: 10.1016/s0006-2952(00)00428-7. Biochem Pharmacol. 2000. PMID: 11007954 Review.

5

Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A. Nioche P, et al. Among authors: vidal m. J Mol Biol. 2002 Feb 1;315(5):1167-77. doi: 10.1006/jmbi.2001.5299. J Mol Biol. 2002. PMID: 11827484

6

Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement.

Saci A, Liu WQ, Vidal M, Garbay C, Rendu F, Bachelot-Loza C. Saci A, et al. Among authors: vidal m. Biochem J. 2002 May 1;363(Pt 3):717-25. doi: 10.1042/0264-6021:3630717. Biochem J. 2002. PMID: 11964172 Free PMC article.

7

Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs.

Liu WQ, Vidal M, Olszowy C, Million E, Lenoir C, Dhôtel H, Garbay C. Liu WQ, et al. Among authors: vidal m. J Med Chem. 2004 Feb 26;47(5):1223-33. doi: 10.1021/jm031005k. J Med Chem. 2004. PMID: 14971902

8

Affinity chromatography for purification of the modular protein growth factor receptor-bound protein 2 and development of a screening test for growth factor receptor-bound protein 2 Src homology 3 domain inhibitor using peroxidase-linked ligand.

Gril B, Liu WQ, Lenoir C, Garbay C, Vidal M. Gril B, et al. Among authors: vidal m. Anal Biochem. 2006 Apr 1;351(1):93-9. doi: 10.1016/j.ab.2005.12.032. Epub 2006 Jan 20. Anal Biochem. 2006. PMID: 16480678

9

Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel.

Gril B, Vidal M, Assayag F, Poupon MF, Liu WQ, Garbay C. Gril B, et al. Among authors: vidal m. Int J Cancer. 2007 Jul 15;121(2):407-15. doi: 10.1002/ijc.22674. Int J Cancer. 2007. PMID: 17372910 Free PMC article.

10

Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.

Goncalves V, Gautier B, Coric P, Bouaziz S, Lenoir C, Garbay C, Vidal M, Inguimbert N. Goncalves V, et al. Among authors: vidal m. J Med Chem. 2007 Oct 18;50(21):5135-46. doi: 10.1021/jm0706970. Epub 2007 Sep 27. J Med Chem. 2007. PMID: 17900101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,004 results

Search Page

Filters